3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
39
Squamous Cell Carcinoma of Head and Neck
20
Lung Neoplasms
20
Oropharyngeal Neoplasms
9
Parkinson Disease 4, Autosomal Dominant Lewy Body
8
Urinary Bladder Neoplasms
7
Uterine Cervical Neoplasms
6
Endometrial Neoplasms
6
Carcinoma
6
Pancreatic Neoplasms
5
Mouth Neoplasms
5
Colorectal Neoplasms
5
Cholangiocarcinoma
5
Biliary Tract Neoplasms
5
Neoplasms
4
Neoplasm Metastasis
4
Nasopharyngeal Carcinoma
4
Laryngeal Neoplasms
4
Head and Neck Neoplasms
4
Carcinoma, Squamous Cell
4
Mesothelioma, Malignant
3
Lymphoid Interstitial Pneumonia
3
Hypopharyngeal Neoplasms
3
Esophageal Squamous Cell Carcinoma
3
Triple Negative Breast Neoplasms
2
Tongue Neoplasms
2
Stomach Neoplasms
2
Small Cell Lung Carcinoma
2
Salivary Gland Neoplasms
2
Rectal Neoplasms
2
Interventions
Oxaliplatin
3
Leucovorin
3
Fluorouracil
3
Capecitabine
3
zolbetuximab
2
trastuzumab deruxtecan
2
pembrolizumab
2
Ramucirumab
2
Paclitaxel
2
repotrectinib
1
lenvatinib
1
fludarabine
1
enzalutamide
1
durvalumab
1
darolutamide
1
aldesleukin
1
Vinorelbine
1
Radiosurgery
1
Radiation
1
Prednisone
1
Prednisolone
1
Positron-Emission Tomography
1
Pemetrexed
1
PF06821497
1
Nivolumab
1
Negative-Pressure Wound Therapy
1
Microscopy, Confocal
1
MORAb-202
1
Irinotecan
1
Immunotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Adenocarcinoma
×
Cisplatin
×
30 days
×
Clear all
NCT06564844
2026-05-22
TROPION-Lung12
AstraZeneca
Phase 3
Active not recruiting
25 enrolled